throbber
12864
`
`Biochemistry 1993, 32, 12864-12874
`
`Mechanism for the Rotamase Activity of FK506 Binding Protein from Molecular
`Dynamics Simulationst
`
`Modesto Orozco,* Julian Tirado-Rives, and William L. Jorgensen•
`Department of Chemistry, Yale University, New Haven, Connecticut 06511-8118
`Received June 4, 1993; Revised Manuscript Received September 13, 19938
`
`ABSTRACT: Molecular dynamics (MD) and free energy perturbation (FEP) methods are used to study the
`binding and mechanism of isomerization of a tetrapeptide (AcAAPFNMe) by FK506 binding protein
`(FKBP). Detailed structures are predicted for the complexes of FKBP with the peptide in both ground-state
`and transition-state forms. The results support a mechanism of catalysis by distortion, where a large
`number of non bonded interactions act together to stabilize preferentially the twisted transition state. The
`two most important groups for the catalysis are suggested to be Trp59 and Asp37, but several other groups
`are identified as directly or indirectly involved in the binding and catalysis. However, the structural results
`do not support the notion that the keto oxygen of the immunosuppressive agents FK506 and rapamycin
`mimics the oxygen for the twisted peptide bond in the FKBP-transition-state complex.
`
`The isomerization of peptidic bonds is a difficult process
`with free energy barriers typically being 15-20 kcaljmol
`(Drankenberg & Forsen, 1971; Larive & Rabenstein, 1993).
`Most peptides correspond to secondary amides and are found
`exclusively in the trans conformation, which is about 2.5 kcal/
`mol more stable than the cis (Drankenberg & Forsen, 1971).
`However, the tertiary nitrogen in prolyl residues allows the
`coexistence of cis and trans isomers in proteins, which may
`require interconversion during protein folding. Considering
`the difficulty of this reaction, and the need for efficient folding
`mechanisms in vivo, the existence of enzymes which catalyze
`the isomerization of prolylpeptides (peptidylprolyl isomerases
`(PPis)) is not surprising. PPis were first characterized by
`Fischer and co-workers (Fischer et al., 1984), and since then
`different studies have demonstrated that these enzymes
`catalyze the cis++ trans isomerism of prolylpeptides during
`the folding of various proteins (Fischer & Bang 1985,
`Biichinger, 1987; Lang et al., 1987; Jackson & Fersht, 1991).
`The interest in two PPis, FKBP (FK506 binding protein)
`and cyclophilin, increased dramatically after the discovery
`that they are receptors for the immunosuppressant agents
`FK506 (Harding et al., 1989) and cyclosporin (Fischer et al.,
`1989a;Takahashi, eta!., 1989). Particularly, FKBPwasfound
`to be the receptor for a family of immunosuppressant drugs
`which includes FK506, rapamycin, and ascomycin. It was
`demonstrated that the binding of the drugs to the protein
`yields complexes which inhibit T-cell activation (see Rosen
`& Schreiber, 1992).
`FKBP is a small, and highly conserved cytosolic protein,
`which was isolated and purified by Schreiber and co-workers
`(Harding et al., 1989), who also cloned the protein (Standaert
`et a!., 1990), and determined the 3-D structure in solution
`(Michnick et al., 1991) and in the crystal (van Duyne et a!.,
`1991). Actually, 3-D structures of the protein as well as of
`the protein bound to FK506 (van Duyne et a!., 1991a),
`rapamycin (van Duyne eta!., 1991b), and ascomycin (Mead(cid:173)
`ows eta!., 1993) are available. The protein's structure features
`
`t This work was supported by NIH Grant GM32136 and a fellowship
`from the Fullbright Foundation.
`* To whom correspondence should be addressed.
`I On leave from the Department de Bioqulmica, Facultat de Qulmica,
`Universitat de Barcelona, Marti Franqu~ 1, Barcelona 08028, SPAIN.
`8 Abstract published in Advance ACS Abstracts, November I, 1993.
`
`a five-stranded antiparallel {3 sheet and a short amphipathic
`a helix, which partially covers one face of the {3 sheet. The
`active site, defined as the region where the protein binds the
`drugs, is located between the a helix and the {3 sheet in a
`hydrophobic pocket formed by the side chains of Trp59, Tyr26,
`Phe46, Phe36, Phe99, Ile56, Tyr82, and Val55,
`Both FK506 and rapamycin bind to FKBP as surrogates
`ofprolylpeptides inhibiting the PPI activity (Schreiber, 1991;
`Rosen & Schreiber, 1992). The low Ki and the presence of
`a C9-keto oxygen orthogonal to the pipecolinyl ring suggest
`that both drugs interact with FKBP as mimics of the transition
`state for cis++ trans isomerization. The fact that cyclosporin,
`a potent immunosuppressant drug, was a powerful inhibitor
`of the PPI activity of cyclophilin led to the speculation that
`the immunosuppressant effects of these drugs were associated
`with their inhibition of PPI activity (see Rosen & Schreiber,
`1992). This attractive hypothesis was ruled out by two
`observations: (i) rapamycin and FK506 have very different
`mechanisms for immunosuppressant activity, although their
`inhibition of PPI activity is similar (Bierer et al., 1990a), and
`(ii) the analog 506BD is a strong inhibitor of FKBP but is not
`an immunosuppressant (Bierer et al., 1990b). Accordingly,
`the relationship, if any, between the PPI and immunophilin
`activities of FKBP and cyclophilin remains to be determined.
`The mechanisms for the PPI action of the immunophilins
`are also obscure. Fischer and co-workers (Fischer et al.,
`1989b) proposed a mechanism based on the formation of
`covalent adducts between the peptide and protein. Kofron et
`al. (1991) suggested an alternative mechanism in which the
`protonation of the proline nitrogen would facilitate the
`isomerization process. Other authors (Albers et al., 1990;
`Harrison & Stein, 1990;Parket al., 1992; Rosen & Schreiber,
`1992) have suggested a mechanism based on the preferential
`stabilization of the transition state by non bonded interactions
`(catalysis by distortion). However, the lack of a structure for
`a complex between an immunophilin and a peptide has limited
`the experimental characterization of the rotamase mechanism.
`In this paper, we present a molecular dynamics (MD) study
`on the mechanism of peptide isomerization catalyzed by FKBP.
`Kinetic measurements have been made for cis -
`trans
`isomerization of tetrapeptides (Fischer et al., 1989; Albers et
`
`0006-2960/93/0432-12864$04.00/0
`
`© 1993 American Chemical Society
`
`

`
`Mechanism for Rotamase Activity
`
`Biochemistry, Vol. 32, No. 47, 1993
`
`I2865
`
`Ala2
`
`0
`
`~
`
`'1'4
`
`Ame6
`
`N/
`I
`
`Phe~0
`)l:Jr j~ Jt,~~"H H
`I'} tr lfvz ,
`
`Ace!
`
`H
`
`0
`
`Ala3
`Pro4
`FIGURE 1: Structure and nomenclature of the peptide used in the
`simulations.
`
`al., 1990; Harrison & Stein, 1990; Kofron et al., 1991; Harrison
`& Stein, 1992; Park et al., 1992). Consequently, structures
`for the complexes of a tetrapeptide with a cis peptide bond
`and of its transition state were sought and obtained here.
`Support for the model includes free energy results for mutation
`of the PI residue. Specific interactions responsible for selective
`stabilization of the transition state are identified. The model
`clarifies in detail the mechanism of rotamase action and is
`open to experimental testing. The binding insights should
`also be useful in the design of high-affinity ligands for FKBP
`with potential immunosuppressive activity.
`
`COMPUTATIONAL METHODS
`
`A peptide with the sequences Ace-Ala-Ala-Pro-Phe-Ame,
`where Ace (acetate) and Arne (methylamide) are theN- and
`C-terminal groups, was used to mimic the natural substrate.
`Figure I shows the structure and related nomenclature; in the
`following, plain numbering is used for the peptide residues
`and superscript numbering is used for protein residues. This
`sequence was selected because is resembles closely the synthetic
`peptides (Suc-Ala-X-Pro-Phe-pNA) used to measure the
`activity of PPis (Fischer et al., I989; Albers et al., I990;
`Harrison & Stein, I990; Kofron et al., 1991; Parket al., 1992).
`The peptide was built in both cis and twisted conformations
`around the Ala3-Pro4 peptidic bond. The peptide in the cis
`conformation is used as a model of the substrate, and the
`twisted conformation, as a model for the transition state.
`The molecular dynamics calculations were carried out with
`the AMBER program, version 4.0 (Pearlman et al., I991).
`The AMBER/OPLS force field (Weiner et al., 1984;
`Jorgensen & Tirado-Rives, I988; Jorgensen & Severance,
`I990) was used to describe both the peptide and the protein
`interactions; the only modifications (see Table I) were for the
`peptidic bond Ala3-Pro4, where the torsional barrier and
`improper torsion at nitrogen were removed (in both planar
`and twisted conformations), and the bond lengths and angles
`at N(Pro4) were assigned to average values for planar and
`twisted amides (Duffy et al., 1992). The stretching and
`bending parameters related to N(Pro4) were reduced in order
`to allow the peptide to accommodate easily to the protein
`environment. Four constraints were used to guarantee that
`the Ala3-Pro4 peptidic bond stayed in the cis or twisted
`conformation. The same force constants were used for both
`conformers in order to make comparable the Hamiltonians
`for the cis and twisted peptides (Table I). The contribution
`of these constraints to the total energy was not included in any
`of the simulations.
`Standard OPLS Leonard-Jones parameters were used for
`the cis and twisted structures (Jorgensen & Tirado-Rives,
`1988; Jorgensen & Severance, 1990). Standard OPLS charges
`for amides were also used to describe the planar structure
`(Jorgensen & Tirado-Rives, I988), while the charges for the
`
`Table 1: Force Field Parameters for the Ala3-Pro4 Peptide Bond•
`
`bond or angle
`C-NW
`C-NW-CH
`C-NW-CQ
`CH-NW-CQ
`
`equil. value
`1.39
`115.0
`115.0
`114.0
`
`force constant
`100
`5
`5
`5
`
`dihedral angle
`Ca(A3)-C(A3)-N(P4)-Ca(P4)
`O(A3)-C(A3)-N(P4)-Ca(P4)
`C(A3 )-N (P4 )-CD(P4 )-Ca(P4)
`Ca(A3)-C(A3)-0(A3)-N(P4)
`
`equil. value
`120/0
`-60/180
`-120/180
`180/180
`
`force constant
`200
`200
`100
`100
`
`q (cis)
`atom
`q (Twisted)
`Ca(A3)
`0.340
`0.200
`C(A3)
`0.500
`0.437
`O(A3)
`--0.457
`--0.500
`N(P4)
`--0.570
`--0.570
`0.285
`Ca(P4), CD(P4)
`0.225
`• The atom type NW corresponds toN (Pro4) of the twisted conformer;
`other atom types are from the standard AMBER/OPLS force-field
`(Weiner eta!., 1984; Jorgensen & Tirado-Rives, 1988). Distances are
`in A, angles in deg, charges in electrons, and force constants in kcaljmol
`A2, or kcalfmol rad2• The dihedral parameters are used as constrains
`to keep the cis or twisted conformation. Standard AMBER torsional
`parameters for the Ala3-Pro4 bond are removed.
`
`twisted amide bond were derived from recent calculations on
`twisted dimethylacetamide (see Table I and Duffy et al.
`(1992)). These charges correctly reproduce properties of
`amides in solution, including free energies of hydration
`(Jorgensen & Tirado-Rives, 1988; Duffy et al., 1992).
`The crystal structure of FKBP bound to rapamycin (van
`Duyne et al., 1991 b) was used as a starting point for the
`calculations. First, the peptide in the twisted form was overlaid
`on rapamycin. The conformation of the peptide was modified
`by rotation around single bonds to obtain the best fit with
`rapamycin and to reproduce well the environment of analogous
`hydrogen bond donor and acceptor groups. Once a suitable
`conformation of the peptide was obtained, the drug was
`removed, yielding a protein-peptide complex in which the
`peptide not only reproduces the general shape of rapamycin
`but also has a similar pattern of hydrogen bonds with the
`binding pocket.
`The protein-peptide model was solvated with a sphere of
`23-A radius containing TIP3P water (Jorgensen et al., 1983)
`centered on the center of mass of the peptide. This led, after
`removal of water molecules with unreasonably short contacts,
`to a solvation sphere with 1002 water molecules. A soft
`harmonic term with a force constant of 1.5 kcal/ (mol A2) was
`used to retreive water molecules drifting beyond the boundary
`of the sphere. The resulting system is shown in Figure 2,
`where it is clear that the sphere of water provides extensive
`hydration of the binding site for the MD calculations. The
`solvated system was then divided into two regions: (i) an
`inner part, which includes the peptide, the water, and all
`residues which have at least one atom closer than I2 A to any
`atom of the peptide, and (ii) an outer part, which contains the
`rest of the protein. The first part includes 78 residues of the
`protein and was free to move in all minimizations and MD
`simulations, while the outer part with 25 residues was kept
`rigid in all calculations. This initial system was then prepared
`through 2000 steps of energy minimization (500 where the
`peptide and the protein were kept rigid, 500 where only the
`peptide was fixed, and 1000 where the entire system was
`minimized), and 40 ps of MD for heating from T = 198-298
`K and equilibration. The final equilibrated structure was
`used to run 500 ps of constant temperature MD at 298 K. The
`
`

`
`12866 Biochemistry, Vol. 32, No. 47, 1993
`
`Orozco et at.
`
`Pc-,llja-Aia-Pn>-Phe-Arre
`ds
`
`~-1
`
`.Ao-.61a.Qy-Poo-l'he-Arre
`ds
`
`AG"...,
`
`Act..,
`
`Pc-,llja-Aia-i'n>-f'he-Arre
`Misled
`
`1~
`
`.Ao,tla~n>-Phe-Arre
`Misled
`
`f iGURE 3: Thermodynamic cycle used to determine the t:J.t:J.G• of
`isomerization between the Ala and Gly peptides. Dark lines are the
`peptide and light lines are the rapamycin molecule.
`
`~1•1 AX
`- kTln (exp(-(Vx,+~ - V~,)/kTJh,
`b.G = )
`~
`
`(I)
`
`wide sampling windows of 5 ps each (2 ps of equilibration and
`3 ps of averaging) for a total of 205 ps for each mutation. T he
`entire peptide was considered as the perturbed group in the
`mutation; not only the intergroup interactions, but also all the
`intragroup nonbonded interactions (including I~) were
`considered in the evaluation of the free energy changes. We
`had determined in pilot calculations that the explicit inclusion
`of bonded contributions in the free energy calculation led to
`increased noise in the final free energies, but did not alter
`significantly the final results. The averaging in eq I was
`performed by MD simulations at constant T = 298 K. where
`T is the temperature, k is Boltzmann's constant, >. is the
`coupling parameter, which controls the evolution of the Ala
`- Gly mutation, and v~ is the potential energy of the system.
`A similar simulation was performed to determine whether
`or not the structure of the cis peptide was able to explain
`experimental binding data (Parker et at., 1992). Thus, the
`difference in free energy of binding between Ala and Gly
`(cis}peptides (b.b.Gbind) was determined as the difference
`between the free energy changes in the mutation Ala- Gly
`in water (b.Gmutwat••), and in the protein complex (b.GmutP'01
`) .
`In order to compute b.Gmutwater the Ala (cis)peptide in the
`conformation adopted inside FKBP at the end of the MD was
`introduced into a cubic box (edge "" 30 A) of TIP3P water.
`The closest water molecules were removed to yield to a system
`with 807 water molecules. The system was minimized for
`3000 cycles (2000 with the peptide fixed and 1000 with the
`entire system free). The system was heated from 198 to 298
`K during 5 ps of NVT MD (during the first 3 ps only the
`water was allowed to move), and equilibrated during 20 ps of
`N PT M D (T = 298 K; P = I atm). The free energy change
`for the Ala- Gly mutation was computed using 41 double(cid:173)
`wide sampling windows of 2.5 ps ( 1.25 ps of equilibration and
`1.25 ps of averaging) for a total of I 02.5 ps. Periodic boundary
`conditions were used in all the simulations. All the remaining
`technical details of the simulations were identical to those
`noted above for the peptide-protein complexes.
`
`RESULTS
`
`Transition-State Structure. The structure of the twisted
`transition state model, which was obtained after the fitting,
`optimization, and equilibration process resembles the general
`
`FIGURE 2: FKBP- peptide complex inside the 23-A sphere of water
`used in the MD simulations.
`
`integration step was 0.002 ps, and the coordinates were stored
`every 0.2 ps. SHAKE (Ryckaert et al., 1977} was used to
`maintain all bonds lengths at their equilibrium values. A
`nonbonded spherical cutoff of 8 A and a residue-based
`non bonded list, updated every 25 integration steps, were used.
`The structure at t = 100 ps was used to generate the cis
`peptide- protein complex. The change between twisted and
`cis peptides was done in six steps with the angles of the
`constraints and the charges gradually modified from twisted
`to cis values (Table I). After each change, the peptide alone
`was optimized in vacuo for I 00 cycles; harmonic constraints
`were used to guarantee that mostoftheconformational changes
`would occur mainly in the Ala3- Pro4 area. This simple
`procedure mimics a fast change from twisted to cis, and we
`found it to be superior to other methods such as stepwise
`rotation for the full protein- peptide system and simulated
`annealing.
`The cis peptide was then placed inside the binding pocket
`of the solvated protein occupying the same location as the
`twisted conformer. The system was optimized, heated, and
`equilibrated during 40 ps using a procedure analogous to that
`described above. A 500-ps MD trajectory was then run for
`the cis system. It should be noted that the cis and twisted
`systems contain the same number of atoms, identical definition
`of the hydration shell, identical partitioning between the inner
`and outer regions, and, except for the charges, the same
`Hamiltonian.
`Free energy ca leu Ia t ions were used to predict the difference
`in isomerization rate between two peptides, Ace-Ala-Ala(cid:173)
`Pro-Phe-Arne and Ace-Ala -G ly-Pro-Phe-Ame, for comparison
`with experimental data on thecorrespondingSuc-Aia-X-Pro(cid:173)
`Phe-pNA peptides (Albers et al., 1990; Harrison & Stein,
`1992; Park et at., 1992). The thermodynamic cycle in Figure
`3 was utilized to obtain the change in free energies of activation.
`The free energy changes for the Ala3- Gly3 mutations was
`computed by statistical perturbation theory according to eq
`1 (Zwanzig, 1954}. These mutations were started with the
`structures and velocities of the cis and twisted systems at the
`end of the MD runs. The calculations were done in 41 double-
`
`

`
`Mechanism for Rotamase Activity
`
`Biochemistry, Vol. 32, No. 47, 1993 12867
`
`FIGURE 4: Superposition of the structures of bound rapamycin and the twisted peptide after the equilibration.
`
`ALA2
`180.0 .-----..----..-------,--~---....
`o +I
`•
`llf}
`
`120.0
`
`60.0
`
`e
`~
`~ 0
`
`-6o.o
`
`-120.0
`
`ALA3
`
`120.0
`
`60.0
`
`e
`~
`~ 0
`
`-6o.o
`
`-120.0
`
`140.0
`
`340.0
`240.0
`t(ps)
`
`440.0
`
`540.0
`
`140.0
`
`340.0
`240.0
`t(ps)
`
`440.0
`
`540.0
`
`PR04
`180.0 .-------,---,-~--.----r----,
`
`PHE5
`
`120.0
`
`60.0
`
`0.0
`
`-6o.o
`
`-120.0
`
`e
`~
`~ 0
`
`e
`! 0
`
`-6o.o
`
`-120.0
`
`140.0
`
`340.0
`240.0
`t(ps)
`
`440.0
`
`540.0
`
`-180.0 L-~--L..~~-'-----'-~.....L........L....-
`40.0
`140.0
`240.0
`340.0
`440.0
`540.0
`t(ps)
`
`FIGURE 5: Dihedral angle histories for the twisted peptide.
`
`structure of rapamycin, as shown in Figure 4. The main chain
`of both molecules overlaps well, and the H-bond donors and
`acceptors are also in proximal positions. In particular, O(Ala3)
`is placed very close to the keto oxygen of rapamycin, and the
`Pro ring shares the space of the pipecolinyl ring.
`Analysis of the 500 ps trajectory shows flexibility in the
`peptide, especially for the side chain of Phe5 and in the Ala3-
`Pro4 region. The histories for the main chain dihedral angles
`shown in Figure 5 reveal that most movements are short range
`oscillations, which do not lead to dramatic changes in the
`structure. However, there is also a systematic movement
`
`occurring for the Ala3-Pro4 region in the 80-120 ps period,
`which leads to a significant change in the relative orientation
`of the peptide inside the protein, as shown in Figure 6. The
`conformation of the 60 and 540 ps structures are similar, as
`noted in Figures 5 and 6 with a general "turn" topology
`stabilized by one or two intrachain hydrogen-bonds. The
`largest differences between the 60 ps and 540 ps structures
`are in the positioning of the proline ring and Ala3-Pro4 with
`respect to the binding site (see Figures 6 and 7). The reduction
`in 1/1 for Ala3 after 60 ps secures the hydrogen bonds for the
`turn structure and leads to better possitioning of the Ala3
`
`

`
`12868 Biochemistry, Vol. 32, No. 47, 1993
`
`Orozco et al.
`
`O(Aia3)
`
`Twisted 60 ps
`
`O(AJa3}
`
`Twisted 540 ps
`
`keto
`
`Rapamycin
`
`FIGURE 6: Representation of the structure adopted inside the binding site by rapamycin, and the twisted peptide at 60 and 540 ps. A common
`reference axis was used to orient the molecules.
`
`FIGURE 7: The twisted peptide bound to the active site of FKBP.
`carbonyl group with respect to theAspl7 side chain (see below).
`The distances for key interactions are shown in Figure 8.
`A hydrogen bond exists between the Asp37 side chain and the
`amino groups of Ala2 and often Ala3, which are proximal
`(Figures 6 and 7). Two intrachain hydrogen bonds are also
`
`common: Ame6- Acel, and Phe5- Ala2, which stabilize the
`turn structure. Another interesting interaction is the close
`contact (ca. 2.0 A) between the amide hydrogen of Phe5 and
`the N of Pro4. There are no hydrogen bonds between the
`oxygen of Ala3 and the protein. The analysis of Figure 8
`
`

`
`Mechanism for Rotamase Activity
`
`Biochemistry, Vol. 32, No. 47, 1993 12869
`
`6.0
`
`5.0
`
`g g 4.0
`i 3.0
`
`2.0
`
`d(O(P4)-NH(I56))
`
`d(0(3)-002(037))
`6.0 ,---,,.,....--.----n-----n
`
`d(C(I\3)-002(037))
`6.0 ,...--.,.--rr---.--------n
`
`5.0 < ..., 4.0
`g
`;! 3.0
`'6
`2.0
`
`5.0
`
`g g 4.0
`!!! 3.0
`.g
`
`2.0
`
`360.0
`200.0
`t(ps)
`
`520.0
`
`1.0 .'-:---:-:-"--:--:-:-':-::--:-:-':"
`520.0
`360.0
`200.0
`40.0
`t(ps)
`
`1·~.0
`
`360.0
`200.0
`t(ps)
`
`520.0
`
`d(HN(Ame)-O(Ace))
`6.0 I"'T"r----r--....----,-,
`
`d(HN(A2)-002(037))
`6.0 ,-----,...---.------.,
`
`5.0 g g 4.0
`
`~ 3.0
`'6
`
`2.0
`
`5.0
`
`d(HN(I\3)-002(037))
`6.0 r-----r--.--------n
`< ..., 4.0
`g
`~ 3.0
`'6
`
`5.0
`
`2.0
`
`g
`«> 4.0
`g
`~ 3.0
`'6 2.0 ~~..,_ . . . . . . . ~
`1.0 .'-:---:-:-"--:--:-:-':-::--:-:-':"
`360.0
`200.0
`520.0
`360.0
`200.0
`40.0
`t(ps)
`t(ps)
`FIGURE 8: Histories for selected interatomic distances during the MD simulation for the twisted peptide.
`
`520.0
`
`360.0
`200.0
`t(ps)
`
`520.0
`
`reveals that the movements during the 80-120 ps period have
`two major consequences: first the hydrogen bond between
`IleS6 and Pro4, which mimics one of the hydrogens bonds in
`the crystal structure of the FKBP- rapamycin complex is lost,
`and second, the intrapeptide hydrogen bond between Ame6
`and Ace! is formed. Two less dramatic, but particularly
`significant changes, are in the distances between the Asp37
`side chain and the C= O moiety of Ala3. In the starting
`conformation, one of the negatively charged ox ygens of Asp37
`is about 3.6 A from O{Ala3) and 4.0 A from C{Ala3), while
`in the final conformation these distances are around 4.7 and
`3.9 A, respectively. Thus, the conformational change in the
`80-120-ps period transforms a clearly bad charge~ipole
`contact into a much more favorable one. It is also notable
`that after the conformational change, the position of the
`carbonyl oxygen of Ala3 is more similar to that of the amide
`oxygen rather than the keto oxygen of rapamycin.
`T he movement of the O(Aia3) from the starting to the final
`conformation leads to a modest reduction in the number of
`aryl interactions (a contact O{Ala3)-H (aromatic) is con(cid:173)
`sidered as an aryl interaction when the Q ... H distance is Jess
`than 3.2 A) between O(Ala3) and the aromatic side chains
`of Phe36, Phe99, Tyr26, and T yr82 from 2.6 to 2.0. Analysis
`of the hydration of the peptide used a geometric definition of
`a hydrogen bond requiring an N···H or O···H distance less
`than 2.5 A, and a donor- hydrogen- acceptor angle between
`120 and 180°. With this definition, there a re initially 5.4
`waters hydrogen bonded to the peptide on average. This
`number increases to 5.8 in the last 240 ps of the trajectory.
`One water is bound to O(Aia2), 1.3 to O(Acel ), and 1.5 to
`O(Phe5); however, the latter's intra peptide hydrogen bonding
`partner, the amino group of Ame6, is hydrogen bonded to a
`water only 10% of the time. 0(Pro4) is not solvent exposed
`in the starting conformation where it is H-bonded to IJe56, but
`in the final part oft he trajectory (100- 540 ps) it is hydrogen
`bonded to an average of 1.1 water molecules. Finally, O(Ala3)
`is in a purely hydrophobic place during the first 320 ps of the
`trajectory, but at this point, it captures a water molecule,
`which remains hydrogen bonded during 80% ofthe remaining
`time as in Figure 7 (an averageof0.4 water is bound to0(Aia3)
`when the complete trajectory is considered).
`
`O(Ala3)
`
`Cis 540 ps
`FIG URE 9: Representation of the conformation adopted inside the
`active site by the cis peptide. Only the structure at the end of the
`MD run is shown, since no major changes occur for the cis peptide
`during the simulation.
`
`The last step in the analysis of the protein-peptide
`interactions was identifying water bridges connecting polar
`groups of the peptide and the protein. There is a water bridge
`between 0(Phe5) and the carbonyl of Glu54 during 55% of
`the time, mimicking another one of the hydrogen bonds in the
`FK BP-rapamycin structure. A water bridge is also detected
`43% of the time between O(Ala2) and His87, and one exists
`40% of the time in the 120-320-ps period between O(Pro4)
`and T yr82, T he latter bridge is lost in the final part of the
`MD, when the water on O(Ala3) makes a bridge to the
`hydroxyl group of Tyr82 during 80% of the time (Figure 7).
`Cis Conformation. The cis form of the bound peptide also
`has a turn structure, with obvious similarities to the structures
`of ra pamycin and the twisted peptide (Figure 9). The position
`of the peptide in the binding site is very similar to that of
`rapamycin, with the proline ring replacing the pipecolinyl
`ring. The MD provides significant sampling of the config(cid:173)
`urational space of the peptide, but no systematic changes occur,
`as evident in the distributions of main chain dihedral angles
`shown in Figure I 0. Key interactions are indicated in Figures
`II and 12. Thus, the Asp37 side chain is again hydrogen
`bonded to the amino group of Ala2, and often to the amino
`group of Ala3. Hydrogen bonds also form ocasionally between
`
`

`
`12870 Biochemistry, Vol. 32, No. 47, 1993
`
`Orozco et a!.
`
`0'
`CD e Cl
`
`CD
`~
`CD
`"6l c:
`cu
`...
`iii
`'0
`CD
`.J:;
`0
`
`ALA2
`180.0 ..-~--,-~---,-----,---.,.------,
`
`120.0
`
`60.0
`
`0.0
`
`,_.
`
`XX
`
`X
`.
`
`-60.0
`
`-120.0
`
`-180.0
`40.0
`
`140.0
`
`~)~~--~~~;;.~
`; -~ •' "~. ~-. :'.-~.··. . -~·':.
`.... ~. :
`.
`
`240.0
`340.0
`t{ps)
`
`440.0
`
`540.0
`
`180.0
`
`PR04
`
`120.0
`
`0'
`CD e
`~ 60.0
`~
`CD
`"6l
`c: cu
`...
`iii
`'0
`CD
`.J:;
`i5
`
`0.0
`
`-60.0
`
`-120.0
`
`ALA3
`
`0 +2
`'lf2
`X
`
`180.0
`
`120.0
`
`60.0
`
`0.0
`
`-60.0
`
`-120.0
`
`-180.0
`40.0
`
`140.0
`
`340.0
`240.0
`t{ps)
`
`440.0
`
`540.0
`
`PHE5
`
`180.0
`
`120.0
`
`60.0
`
`0.0
`
`-60.0
`
`-120.0
`
`0 +4
`'lf4
`X
`
`0'
`~
`
`Cl
`CD
`~
`CD
`"6l
`c: cu
`e
`
`'0
`CD
`.J:;
`0
`
`0'
`~
`
`Cl
`CD
`~
`CD
`"6l
`c: cu
`... -g
`iii
`
`.J:;
`
`i5
`
`-180.0
`40.0
`
`140.0
`
`240.0
`340.0
`t{ps)
`FIGURE 10: Dihedral angle histories for the cis peptide.
`
`440.0
`
`540.0
`
`-180.0
`40.0
`
`140.0
`
`340.0
`240.0
`t(ps)
`
`440.0
`
`540.0
`
`""i
`
`FIGURE 11: The cis peptide bound to the active site of FKBP.
`NH(Ame) and O(Ala2) and between NH(Phe5) and O(Ala2).
`Other H-bonds (not shown in Figure 12) that are present
`some of the time are between NH(Phe5) and the imidazole
`ring of His87 and between NH(Ame) and O(Pro4). A
`hydrogen bond exists between O(Ala3) and the hydroxyl group
`of Tyr26 only during short periods of time, for instance in the
`160-180-ps period, but most of the time this H-bond is not
`present. It is very interesting to look at the relative positions
`of Asp37 with respect to the carbonyl group of Ala3; the OD2-
`0(Ala3) distance is around 3.3 A, and the OD2-C(Ala3)
`distance is about 4.0 A. These reveal a repulsive charge(cid:173)
`dipolecontact, which contrasts the favorable interaction found
`
`for the transition state. Intra peptide hydrogen bonds that are
`present in the twisted conformation, but are not present in the
`cis structure are between NH (Phe5) and N (Pro4) and between
`NH(Ame) and O(Ace).
`The carbonyl oxygen of Ala3 is near the aromatic side chain
`of Phe99 and Tyr26 (Figure 11); the average number of aryl
`interactions is 1.2 for this oxygen, which is ca. 1 less than in
`the twisted conformation. The cis peptide is well hydrated,
`with an average of 5.0 waters hydrogen bonded (0.4-0.Sless
`than in the twisted structure). A detailed analysis of the
`hydration shell shows that the oxygens of Ace and Phe5 are
`the best hydrated, with an average of 1.9 and 1.8 water
`
`

`
`Mechanism for Rotamase Activity
`
`Biochemistry, Vol. 32, No. 47, 1993 12871
`
`d(HN(F5)-0(A2))
`6.0 .--~-.---,..---r.
`
`d(HN(A2)-002(037))
`6.0 .-----.---....---.,..,
`
`d(HN(A3)-002(037))
`6.0 .------.---....---.,.,
`
`5.0
`
`g g 4.0
`.i 3.0
`
`., 2.0
`
`6.0
`
`5.0
`
`g
`g 4.0
`
`~ 3.0
`'6
`
`2.0
`
`200.0
`360.0
`t(ps)
`
`520.0
`
`d(0(3)-002(037))
`
`5.0 g g 4.0
`~ 3.0
`'6 2.0 ......... u~''lllli"'•l.IJoL.ll(llt.'lllllll•olii.'IJ
`
`1.0 L..-_
`40.0
`
`__._ __ ...._ _ _u
`200.0
`360.0
`520.0
`t(ps)
`
`d(C(A3)-002(037))
`
`6.0
`
`5.0
`
`g
`g 4.0
`
`~ 3.0
`'6
`
`2.0
`
`5.0
`
`g
`~ 4.0
`~ 3.0
`'6 2.0
`
`6.0
`
`5.0
`
`g
`g 4.0
`
`; 3.0
`'6 2.0
`
`200.0
`360.0
`t(ps)
`
`520.0
`
`d(HN(Ame)-O(A2))
`
`1.0
`40.0
`
`200.0
`360.0
`t(ps)
`
`520.0
`
`1.0
`40.0
`
`200.0
`360.0
`t(ps)
`
`520.0
`
`360.0
`200.0
`t(ps)
`
`520.0
`
`FIGURE 12: Histories for selected interatomic distances during the dynamics for the cis peptide.
`
`molecules bound. The oxygens of Pro4 and Ala2 are less well
`solvated with 0.5 and 0.7 water molecule bound on average.
`The amino group of Arne is hydrogen bonded to a water only
`10% of the time. O(A1a3) which is hydrogen bonded to a
`water molecule in the last part of the MD for the twisted
`conformer, is not solvated in the cis conformation. Three
`water bridges exist sporadically; the most common involve
`GluS4 which has water bridges with O(Pro4) and O(Phe5)
`during 31% and 22% of the simulation, respectively. A water
`bridge between O(Ala2) and the imidazole ring of His87 also
`exists 38% of the time during the first 200 ps, but it is rare
`in the remaining 340 ps. Finally, there are no water bridges
`involving Tyr82 and O(Pro4) or O(Ala3), in contrast to the
`twisted conformer.
`Free Energy Calculations. The structures determined for
`both the cis and twisted complexes seem reasonable from the
`viewpoints of stability, interactions, and function. Never(cid:173)
`theless, doubt remains about whether or not they are the real
`conformations. Comparison of total potential energies dem(cid:173)
`onstrates that the twisted form is slightly lower in energy than
`the cis, in good agreement with the proposed stabilization of
`the transition state by the enzyme, but the difference (around
`7 kcaljmol) is not significant considering the statistical noise
`in the simulations (::1::70 kcaljmol). Additional MD calcu(cid:173)
`lations, graphical manipulation, and simulated annealing
`procedures support the correctness of the structures, but it is
`obvious that more quantitative results are desirable. Though
`an experimental 3-D structure of the FKBP-peptide complex
`is not available, attempts could be made to reproduce kinetic
`data for the isomerization catalyzed by the enzyme. One
`possibility was to compute the potential of mean force (PMF)
`for rotation about the Ala3-Pro4 peptidic bond, and to compare
`the tlG of this process with the observed tlG of activation for
`the enzymatic reaction (tlG*). Unfortunately, several at(cid:173)
`tempted PMF calculations using holonomic constrains en(cid:173)
`countered major technical difficulties. Development of
`alternative procedures for such perturbations is under con(cid:173)
`sideration.
`However, some support can be sought by comparison of the
`relative tlG* of peptides with different sequence. Park et al.
`( 1992) found a difference in kcat favoring Ala over Gly at the
`
`P1 position in the Suc-Ala-X-Pro-Phe-pNA peptide. Their
`kca1 ratio of 1200 (T = 278 K) translates to a lower tlG* for
`the Ala(P 1) peptide by 3. 9 kcal/ mol. Harrison & Stein (1992)
`reported a kcatf Km ratio for Ala and Gly peptides of 44 (T
`= 283 K), which considering the Km for these peptides (Park
`et al., 1992) translates to a lowering of tlG* for the Ala(P1)
`peptide by 2.7

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket